Home › Small Cell Lung Cancer › Florida › Orlando
Small Cell Lung Cancer clinical trials in Orlando, FL
14 studies for Small Cell Lung Cancer are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- AdventHealth Cancer Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · 17 mi away
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RecruitingPhase 1/2
- Avenzo Therapeutics Recruiting Site, Orlando
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RecruitingPhase 3
- Clermont Oncology Center, Clermont · 24 mi away
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- Advent Health, Orlando
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RecruitingPhase 3
- Orlando Health Cancer Institute /ID# 280418, Orlando
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RecruitingPhase 1
- Sara Cannon Research Institute Lake Nona, Orlando
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
RecruitingPhase 3
- University of Florida Health Cancer Center at Orlando Health, Orlando
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
- Clermont Oncology Center, Clermont · 24 mi away
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- AdventHealth Celebration, Celebration · 17 mi away
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RecruitingPhase 3
- AdventHealth Orlando, Cancer Institute, Orlando
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- Florida Cancer Specialists, Orlando
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
RecruitingPhase 1/2
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Florida Cancer Specialists-Lake Nona, Orlando
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- New York City, NY23 studies
- Arlington, VA22 studies
- Boston, MA22 studies
- Los Angeles, CA20 studies
- Nashville, TN20 studies
- Chicago, IL13 studies
- Cleveland, OH13 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Washington, DC13 studies
- Detroit, MI12 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer47 studies
- Obesity33 studies
- Alzheimer's Disease29 studies
- Metastatic Cancer28 studies
- Overweight27 studies
- Type 2 Diabetes25 studies
- Ovarian Cancer24 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Lung Cancer23 studies
- Ulcerative Colitis21 studies
- Colorectal Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.